In whom and how to prevent glucocorticoid-induced osteoporosis.
作者： Jonathan D. Adachi , Alexandra Papaioannou
DOI: 10.1016/J.BERH.2005.07.002
关键词:
摘要: … The most common side-effect is osteoporosis. Today we have … for the prevention of vertebral fractures and bone loss. Consequently recognition of glucocorticoid-induced osteoporosis is …
bprclinrheum.com
elsevier.com参考文章(88)
Sebaldt Rj, Bensen Wg, Cividino A, Adachi Jd, Gordon M, Goldsmith Ch, Pillersdorf S, Bianchi F, Steele M, Webber C, Tugwell P, Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. The Journal of Rheumatology. ,vol. 23, pp. 995- 1000 ,(1996)
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
Lenore M Buckley, Bruce E Hillner, A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids. The Journal of Rheumatology. ,vol. 30, pp. 132- 138 ,(2003)
Jacques P. Brown, Wojciech P. Olszynski, Anthony Hodsman, William G. Bensen, Alan Tenenhouse, Tassos P. Anastassiades, Louis-Georges Ste-Marie, David L. Kendler, David A. Hanley, Robert Josse, John G. Hanly, Brian Lentle, Algis Jovaisas, George Ioannidis, Greg F. Stephenson, Ian Barton, Simon Pack, Arkadi Chines, Reginald Dias, Jonathan D. Adachi, Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids. Journal of Clinical Densitometry. ,vol. 4, pp. 363- 371 ,(2001) , 10.1385/JCD:4:4:363
Barbara P. Lukert, Bruce E. Johnson, Ralph G. Robinson, Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss Journal of Bone and Mineral Research. ,vol. 7, pp. 1063- 1069 ,(2009) , 10.1002/JBMR.5650070909
Barbara P. Lukert, Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management Annals of Internal Medicine. ,vol. 112, pp. 352- 364 ,(1990) , 10.7326/0003-4819-112-5-352
R. Eastell, D. M. Reid, J. Compston, C. Cooper, I. Fogelman, R. M. Francis, D. J. Hosking, D. W. Purdie, S. H. Ralston, J. Reeve, R. G. G. Russell, J. C. Stevenson, D. J. Torgerson, A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update Journal of Internal Medicine. ,vol. 244, pp. 271- 292 ,(1998) , 10.1046/J.1365-2796.1998.00408.X
C. N. BERNSTEIN, L. L. SEEGER, P. A. ANTON, L. ARTINIAN, S. GEFFREY, W. GOODMAN, T. R. BELIN, F. SHANAHAN, A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study Alimentary Pharmacology & Therapeutics. ,vol. 10, pp. 777- 786 ,(1996) , 10.1046/J.1365-2036.1996.63205000.X
J. H. Healey, S. A. Paget, P. Williams-Russo, T. P. Szatrowski, R. Schneider, H. Spiera, H. Mitnick, K. Ales, P. Schwartzberg, A Randomized Controlled Trial of Salmon Calcitonin to Prevent Bone Loss in Corticosteroid-Treated Temporal Arteritis and Polymyalgia Rheumatica Calcified Tissue International. ,vol. 58, pp. 73- 80 ,(1996) , 10.1007/BF02529727
T. P. Van Staa, R. F. Laan, I. P. Barton, S. Cohen, D. M. Reid, C. Cooper, Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis & Rheumatism. ,vol. 48, pp. 3224- 3229 ,(2003) , 10.1002/ART.11283